Share

Profile & Fundamentals

RxSight Profile & Fundamentals

Name: RxSight financial chart data preview
Creator: iPulse AI
License: https://ipulseai.com/terms

Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.

Interactive annual & quarterly chartsAI financial reviewsReported source tables

Explore this pageJump to a Profile & Fundamentals section

Explore this research

Profile & Fundamentals contents

Jump directly to any section

Company and Market Context

Company Profile & Ownership

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Company profile record

Rxsight Inc

Common Stock · Health Care · Health Care Supplies

Official website

Company

Company / asset: Rxsight Inc
Security type: Common Stock
Sector: Health Care
Industry: Health Care Supplies
HQ: 🇺🇸 United States
Head office: 100 Columbia, Aliso Viejo, CA, United States, 92656

Leadership & scale

Chief executive: Mr. Aziz Mottiwala M.B.A.
CEO year born: 1978
Full-time employees: 461
Fiscal year end: December
IPO date: 2021-07-30

Fundamentals snapshot

Updated 2026-09-13

Market Cap: USD 213.3M
P/E: --
Revenue (Q2 26): USD 33.7M
Profit (Q2 26): USD -12.1M
Dividend Yield: --
Revenue (FY 25): USD 134.5M
Shares in public float: 33.7M
Insider ownership: 6.48%

Reporting & identifiers

Symbol: RXST.NASDAQ
Listing: 🇺🇸 United States | Dividend Tax: 30%
Ticker Currency: USD
Income Statement Currency: USD
Balance Sheet Currency: USD
Cash Flow Currency: USD
EPS Currency: USD
Contract Type: SPOT
ISIN: US78349D1072
Asset ID: equity_73ac566d-3909-558b-b1ed-6b4754a19ed8

Ownership

Shares Outstanding

Shares outstanding

Annual reported shares outstanding. Values in shares.

Top holders

BlackRock Inc3,187,092 shares · 7.66% · Reported 2026-03-31
Millennium Management LLC3,030,287 shares · 7.29% · Reported 2026-06-30
No Street GP LP2,055,000 shares · 4.94% · Reported 2026-06-30
Nomura Holdings Inc2,000,060 shares · 4.81% · Reported 2026-06-30
D. E. Shaw & Co LP1,985,215 shares · 4.77% · Reported 2026-06-30
Vanguard Capital Management, LLC1,692,935 shares · 4.07% · Reported 2026-03-31
Vanguard MStar Total Stk Mkt Idx Invest1,227,155 shares · 2.95% · Reported 2026-07-31

View more holders (8)

Bank of America Corp1,210,039 shares · 2.91% · Reported 2026-03-31
Federated Hermes Inc1,201,195 shares · 2.89% · Reported 2026-06-30
Two Sigma Investments LLC1,147,048 shares · 2.76% · Reported 2026-06-30
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND1,131,400 shares · 2.72% · Reported 2026-03-31
Jacobs Levy Equity Management, Inc.1,066,321 shares · 2.56% · Reported 2026-03-31
BlackRock Advantage Small Cap Core Instl1,031,448 shares · 2.48% · Reported 2026-07-31
Acadian Asset Management LLC1,019,127 shares · 2.45% · Reported 2026-03-31
iShares Russell 2000 ETF1,012,959 shares · 2.44% · Reported 2026-08-31

Earnings, Profitability & Valuation

Earnings & Revenue

AI Review

Headline financial results show a business navigating a major commercial pivot. Trailing revenue contracted to one hundred twenty-eight million dollars as clinic console purchases fell forty-eight percent in fiscal 2025. However, underlying consumable lens procedure volume grew twelve percent, providing a stable foundation beneath hardware volatility. Second-quarter 2026 revenue stabilized at thirty-three million seven hundred thousand dollars, aided by initial partnership licensing payments. This transition conceals improving underlying business quality behind headline accounting losses. Operating losses reached fifty-five million dollars over the trailing twelve months due to commercial expansion and legal costs. However, cash burn runs at roughly half that level because stock compensation is non-cash, and recurring lens sales are gradually replacing hardware as the primary revenue engine.

Revenue, Net Income, and Free Cash Flow

Revenue
Free cash flow
Net income

Annual reported financial results, converted using the statement's recorded USD conversion. Missing values are omitted. Values in USD.

Valuation

Historical P/E Ratio

The published data is insufficient to draw this chart.

Profitability & Margins

AI Review

Gross profit margins tell a remarkable story of structural improvement beneath headline operating deficits. Corporate gross margins surged from seventy point seven percent in 2024 to seventy-six point six percent in 2025, reaching seventy-six point seven percent in mid-2026. This expansion reflects an advantageous mix shift toward proprietary consumable lenses, which deliver significantly higher profitability than capital delivery consoles. Operating margins remain temporarily depressed at negative thirty-five point eight percent due to dedicated commercial sales infrastructure. However, product unit economics remain robust. As high-margin recurring lens procedures expand across the installed machine base and licensing income flows through with minimal added costs, operating leverage will steadily convert gross profits into sustainable operating earnings.

Profitability Margins

Gross margin
Operating margin
Net margin
Free cash flow margin

Annual gross, operating, net income and free cash flow divided by revenue for matching reporting dates. Values in percent.

Complete Research Workspace

Unlock the complete Profile & Fundamentals

Sign in to verify your access, or upgrade to the Base plan to open the complete profile & fundamentals and available source data.

Sign in to check access View Base plan

Paywalled preview begins: Reported Data Tables — chart preview

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Reported Data Tables — chart preview

The following tables contain the same values as the financial charts above. Monetary values are USD; margins are percentages. Missing inputs are not estimated. Use is subject to the iPulse AI Terms of Service and applicable source rights.

Source: eodhd. Statement snapshots with chart transformations and ratios calculated by iPulse AI. Snapshot retrieved 2026-09-15.

Annual earnings and profitability
Period end	Revenue	Free cash flow	Net income	Gross margin	Operating margin	Net margin	Free cash flow margin
2019-12-31	2,241,000	-44,705,000	126,220,000	-81.17	-2,055.78	5,632.31	-1,994.87
2020-12-31	14,678,000	-37,742,000	27,575,000	11.62	-241.21	187.87	-257.13
2021-12-31	22,593,000	-46,648,000	-48,688,000	19.99	-233.64	-215.5	-206.47
2022-12-31	49,005,000	-61,243,000	-66,756,000	43.52	-129.21	-136.22	-124.97
2023-12-31	89,077,000	-46,407,000	-48,608,000	60.36	-56.23	-54.57	-52.1
2024-12-31	139,927,000	-22,386,000	-27,455,000	70.71	-26.34	-19.62	-16
2025-12-31	134,477,000	-19,341,000	-38,943,000	76.6	-35.84	-28.96	-14.38

Shares outstanding — chart values
Reporting date	Shares outstanding
2020-01-01	19,073,100
2021-01-01	27,352,600
2022-01-01	27,990,300
2023-01-01	35,961,900
2024-01-01	40,356,800
2025-01-01	41,175,700
2026-01-01	41,490,900

End of the paywalled preview

The excerpt from Reported Data Tables — chart preview to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Additional with full access

Earnings, Profitability & Valuation
- Complete profitability ratios
- EPS history and estimate comparisons
- Execution vs expectations
- Annual and quarterly financial views
Capital Expenditure & R&D
- Capital allocation AI review
- Annual capital expenditure
- Investment intensity trends
- Capex and R&D intensity indicators
Balance Sheet
- Balance sheet AI review
- Assets, debt and equity
- Capital structure
- Liquidity and leverage
- Retained earnings
Dividends & Actions
- Cash dividends paid
- Dividend indicators
- Buybacks and issuance
- Combined shareholder returns
- Available corporate actions
Company Events
- Dated insider transactions
- Material company activity

Explore complete public research examples

These public assets show the complete asset profiles, fundamental datasets and analysis. Their findings concern those assets, not this report.